Annals of Surgical Oncology

, Volume 16, Issue 10, pp 2962–2963 | Cite as

In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma

Melanomas

References

  1. 1.
    Morton RL, Howard K, Thompson JF. The cost-effectiveness of sentinel node biopsy in patients with intermediate thickness primary cutaneous melanoma. Ann Surg Oncol. 2009;16:929–40.CrossRefPubMedGoogle Scholar
  2. 2.
    Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol. 2008;5:18–23.CrossRefPubMedGoogle Scholar
  3. 3.
    Morton DL, Cochran AJ, Thompson JF. The rationale for sentinel-node biopsy in primary melanoma. Nat Clin Pract Oncol. 2008;5:510–1.CrossRefPubMedGoogle Scholar
  4. 4.
    van Akkooi AC, de Wilt JH, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17:1578–85.CrossRefPubMedGoogle Scholar
  5. 5.
    Ollila DW, Ashburn JH, Amos KD, et al. Metastatic melanoma cells in the sentinel node cannot be ignored. J Am Coll Surg. 2009;208:924–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Scolyer RA, Murali R, Satzger I, Thompson JF. The detection and significance of melanoma micrometastases in sentinel nodes. Surg Oncol. 2008;17:165–74.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  1. 1.Melanoma Institute Australia and Sydney Melanoma UnitRoyal Prince Alfred and Mater HospitalsNorth SydneyAustralia
  2. 2.Discipline of SurgeryThe University of SydneySydneyAustralia
  3. 3.School of Public HealthThe University of SydneySydneyAustralia

Personalised recommendations